Financial News · Live Terminal

Page 1644 of 2273

Mizuho Securities Adjusts Verastem Price Target to $16 From $18, Maintains Outperform Rating

Verastem (VSTM) has an average rating of Buy and mean price target of $16.38, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $5.38, Change: $-0.09, Percent Change: -1.56%

$VSTM

Wire55d ago

Mizuho Adjusts Price Target on Corbus Pharmaceuticals to $40 From $39, Maintains Outperform Rating

Corbus Pharmaceuticals Holdings Inc (CRBP) has an average rating of buy and mean price target of $41.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $9.87, Change: $+0.04, Percent Change: +0.46%

$CRBP

Wire55d ago

Mizuho Adjusts Price Target on Axsome Therapeutics to $228 From $230, Maintains Outperform Rating

Axsome Therapeutics (AXSM) has an average rating of buy and mean price target of $222.90, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $185.08, Change: $+0.08, Percent Change: +0.04%

$AXSM

Wire55d ago

Mizuho Lifts Price Target on Amylyx Pharmaceuticals to $21 From $19, Maintains Outperform Rating

Amylyx Pharmaceuticals (AMLX) has an average rating of buy and mean price target of $23.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $15.76, Change: $-0.55, Percent Change: -3.37%

$AMLX

Wire55d ago

Dynatrace Well Positioned on Growth Strategy Amid Starboard Activist Push, Wedbush Says

Dynatrace (DT) remains well positioned on its profitable growth strategy amid Starboard Value taking a stake and pushing for faster revenue acceleration, margin expansion, and increased capital returns, Wedbush Securities said in a Wednesday note.Wedbush noted Dynatrace remains focused on balancing revenue growth and margin expansion through ongoing product innovation and platform expansion.Starboard, which has developed a reputation for improving sentiment around companies, has brought up some important points that should be addressed, Wedbush said, adding that Dynatrace has actively engaged with the activist investor to address some of the concerns with its struggling share price.The brokerage said Dynatrace seen as an "AI loser" is not the right approach, given the necessary growing market the company operates in.Wedbush maintained an outperform rating on the stock with a price target of $55.Price: $35.98, Change: $-0.01, Percent Change: -0.03%

$DT

Equities55d ago

Trump Rejects Iran's Offer, Orders Blockade Until Nuclear Deal, Axios Reports

Wire55d ago

Palantir Technologies Could See Lower Contract Values in Q1, RBC Says

Palantir Technologies (PLTR) could see a decline in qualified contract value and net new annual contract value for the second consecutive quarter in Q1, even with the ongoing Middle East conflict, RBC Capital Markets said in a Tuesday note.RBC expected the conflict to serve as a near-term tailwind for the company's government business, but its government tracker indicated a potential decline in Palantir's contract values, according to the note.Meanwhile, concerns remain over the company's commercial business amid stiff competition in the sector, the investment firm noted.Palantir Technologies is set to release its Q1 results on May 4.RBC maintained its underperform rating and $90 price target on Palantir Technologies.Price: $137.06, Change: $-4.12, Percent Change: -2.92%

$PLTR

Wire55d ago

Market Chatter: United Airlines Wary of Pursuing Smaller Acquisitions Like JetBlue

United Airlines (UAL) Chief Executive Scott Kirby said that pursuing an acquisition of a smaller airline like JetBlue Airlines (JBLU) might not be worth the intensive effort required, The New York Times reported Wednesday.In an interview, Kirby told The Times that "doing a merger takes a lot of calories and a lot of energy, and it's about the same amount of calories and energy regardless of the size of the merger."The interview comes just days after Kirby raised the idea of a potential merger with American Airlines (AAL), but was rebuffed, according to the report.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $88.03, Change: $-2.38, Percent Change: -2.64%

$AAL$JBLU$UAL

Research55d ago

Research Alert: Psx: Derivative Headwinds, But A Q1 Beat Nonetheless

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PSX surprised to the upside in Q1 with adjusted EPS of $0.49 vs. a loss of $0.90 in the prior year, beating consensus by $0.88. However, PSX incurred sizable $839M losses on derivative positions against just $200M in adjusted earnings. The WRB acquisition boosted net crude throughput capacity by 45k b/d to 1.993M b/d, while midstream expansion efforts increased Sweeny NGL fractionation capacity by 23% and Freeport LPG export dock capacity by 15%. Upcoming projects include the Iron Mesa gas plant (300 mmcf/d) and two polymers projects, both targeting 2027 startups. Refining utilization remained strong at 95% despite planned turnarounds, though realized margins declined to $10.11/b from $12.48/b sequentially. Midstream volumes pulled back from Winter Storm Fern, with NGL pipeline throughput dropping to 930 MBD vs. 1,006 MBD in Q4. We think the efficiency efforts can support increased LNG and LPG exports to Asia, which faces supply shortages following Strait of Hormuz blockades.

$PSX

Mining & Metals55d ago

Stifel Canada Previews Colliers International's Q1 Results

Stifel Canada is expecting Colliers International's (CIGI.TO, CIGI) first-quarter revenue to increase 10% to US$1.255 billion.Analyst Daryl Young, who is maintaining a buy rating and US$175.00 price target on the shares, is expecting adjusted EBITDA of US$120.2 million (consensus: US$122.1 million) at 9.6% margins (down 60bps y/y). The lower margins reflect investment management (IM) platform integration costs, he says.Young believes the broader fundraising market remains sluggish amid unease related to the Middle East conflict, interest rate volatility, and slower monetization activity. "To be clear, CIGI's IM platform operates in more niche segments of the private markets and has limited direct exposure to current private market challenges, but we think the broader sentiment may be an overhang to fundraising."The company reports its quarterly earnings after market close on May 5.Price: $143.86, Change: $-7.60, Percent Change: -5.02%

$CIGI$CIGI.TO

Research55d ago

Research Alert: CFRA Retains Buy Rating On Shares Of Abbvie Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target at $255, 15.8x our 2026 EPS view. This is above ABBV's 10-year historical forward P/E average of 12.1x, justified by its improving long-term growth prospects. We raise our 2026 EPS view to $14.17 from $14.02 to reflect the Q1 beat and raised expectations for the rest of the year. We keep our 2027 EPS view at $16.13. ABBV reported a strong start to 2026, with Q1 results surpassing expectations. Revenues reached $15B, a 12.4% increase, beating expectations due to the continued momentum in the Immunology and Neuroscience franchises. Adjusted EPS came in at $2.65, above the guidance midpoint despite an unfavorable impact from acquired IPR&D. We think the early data from the Amylin Analog (ABBV-295) showed promising weight loss results with good tolerability. With Phase 2 studies expected to begin in Q3 2026, we think updates should be closely followed as ABBV-295 could well position AbbVie in the highly lucrative obesity market with a potentially differentiated, non-incretin-based mechanism.

$ABBV

Treasury55d ago

CIBC Sees No Reason to Change Its View of Bank of Canada on Hold for The Rest of The Year

The Bank of Canada's decision to leave the policy rate at 2.25% on Wednesday came as no surprise, given the clouded outlook ahead, said CIBC.The BoC assumed that oil prices will gradually decline to US$75/barrel in mid-2027, still lifting near-term inflation but leaving the growth outlook little changed from the prior forecast, one that only makes very gradual progress in eliminating economic slack, noted the bank.CIBC has reason to alter its call for the BoC to be on hold this year. Absent the Middle East conflict, persistent economic slack and downward pressure on core inflation might well have prompted an easing.However, by the time oil prices have sufficiently eased inflation fears, the window for a rate reduction will likely have passed, the bank pointed out. CIBC's core inflation outlook is sufficiently benign to make a rate hike "unwise."BMO is a few ticks faster than the BoC in its outlook for 2027 growth, enough to envisage a couple of quarter-point hikes next year as the output gap narrows, but that is contingent on seeing USMCA talks prevent further trade barriers and provide some small relief from existing sectoral duties imposed on Canada.The Canadian dollar (CAD) was little changed after Wednesday's announcement, and futures markets showed little response in terms of rate expectations for the end of the year, according to CIBC.

$CAD$CXY

Equities55d ago

Street Color: President Trump Rejects Iran's Offer, Keeps Naval Blockade, Axios Reports

Asia Markets55d ago

Swiss Blue-chip Index Extends Losses; UBS Shares Up

Swiss stocks extended their losing streak at Wednesday's close, with the Swiss Market Index down 0.88%, as investors assessed fresh corporate and economic data releases while awaiting the US Federal Reserve's monetary policy decision.The Fed is widely expected to leave its key interest rate unchanged in the 3.5% to 3.75% range later today."Nothing much is expected from this meeting. The March dots showed the Committee median vote leaned toward one cut this year and one more next year. That's unlikely to be settled for a long while yet. [US Fed Chair] Powell is unlikely to be comfortable with teeing up such a move before his successor takes over and he faces eleven other voting FOMC members that are more worried about inflation at the moment," Scotiabank Economics said. "Our forecast remains for one cut by late year and another in early 2027 which would drop the fed funds upper limit rate to 3.25% and hence still on the boundary between restrictive and neutral."Back home, data from UBS & CFA Society Switzerland showed that the country's economic sentiment index increased to -30.3 points in April from -35 points in March.On the corporate front, Sandoz Group's (SDZ.SW) net sales increased to $2.76 billion in the first quarter from the year-ago $2.48 billion, bolstered by an 18% growth in constant-currency net sales at its biosimilars segment. For 2026, the Swiss pharmaceutical major reaffirmed its guidance of a mid-to-high single-digit percentage growth in net sales at constant currency. The stock closed the session 2.23% lower.On the flip side, UBS Group (UBSG.SW) gained 3.22% at closing as it delivered a year-over-year surge in first-quarter net profit attributable to shareholders to $3.04 billion from $1.69 billion. Total revenue also climbed over the period to $14.24 billion from $12.56 billion, mainly driven by double-digit growth in the Swiss banking group's core franchises."We delivered excellent financial results and remain on track to deliver on our financial objectives for 2026 ... Having now successfully transferred all client accounts in Switzerland, we achieved another crucial milestone in one of the most complex integrations in banking history. We are confident in substantially completing the integration by year-end, positioning us for further sustainable growth," Chief Executive Officer Sergio Ermotti said. "On the topic of Swiss capital requirements, we will continue to engage constructively and contribute to fact-based deliberations. These developments do not, and will not, change who we are as a firm."

^SSMI$SDZ.SW$UBSG.SW

Wire55d ago

HSBC Adjusts Coca-Cola Price Target to $90 From $84, Maintains Buy Rating

Coca-Cola (KO) has an average rating of overweight and mean price target of $85.95, according to analysts polled by FactSet.Price: $78.87, Change: $+0.52, Percent Change: +0.66%

$KO

Mining & Metals55d ago

RBC Maintains First Quantum's Outperform Rating, C$45 Price Target

RBC Capital Markets maintained its outperform, speculative risk, rating on the shares of First Quantum Minerals (FM.TO)' and its C$45.00 price target following the company's first-quarter results.RBC expects a modest negative reaction to the results, given a headline miss on EBITDA and adjusted earnings per share.The company reported a first-quarter EBITDA of US$326 million, below RBC's forecast of US$461 million and the consensus estimate of US$448 million.Adjusted loss of US$0.18 per share also missed RBC's EPS forecast of US$0.01 per share and the consensus estimate of US$0.06 per share.First Quantum's financial results were impacted by US$144 million of losses on hedges and from lower sales due to timing and inventory replenishment.Price: $33.64, Change: $-0.65, Percent Change: -1.90%

$FM.TO

Japan55d ago

US Equity Indexes Fall as Iran War Deadlock Sends Crude Oil, Treasury Yields Sharply Higher

US equity indexes traded lower around midday Wednesday as crude oil futures and government bond yields rose amid concern that Iran's blockade will be extended to force Tehran into a peace deal.The Dow Jones Industrial Average fell 0.7% to 48,789.2, with the S&P 500 down 0.2% to 7,122.9. The Nasdaq Composite was 0.2% lower at 24,620.7.President Donald Trump has instructed aides to prepare for an extended blockade of Iran, US officials told The Wall Street Journal. In recent meetings, including a Monday discussion in the Situation Room, Trump opted to continue squeezing Iran's economy and oil exports by preventing shipping to and from its ports, the WSJ said.Trump assessed with his aides that the other options open to him -- resume bombing or walk away from the conflict -- carried more risk than maintaining the country's blockade, the officials told the WSJ."Iran can't get their act together. They don't know how to sign a nonnuclear deal. They better get smart soon!" Trump said in a Truth Social post Wednesday.Meanwhile, West Texas Intermediate crude oil futures jumped 4.9% to $104.86, and Brent crude futures surged 5% to $116.85 amid concern that Trump's policy will prolong disruption in the Strait of Hormuz, the chokepoint for 20% of global crude oil flows.

Dow JonesNasdaq CompositeS&P 500

Wire55d ago

Textron Keeps Quarterly Dividend at $0.02 a Share, Payable July 1 to Shareholders of Record as of June 12

$TXT

Commodities55d ago

Delek Logistics Reports Q1 Throughput Gains in Delaware Basin, Mixed Elsewhere

Delek Logistics (DKL) reported Wednesday Q1 throughput growth across key Permian Basin assets, with mixed volumes across segments compared with a year earlier.In the Delaware Basin, natural gas gathering and processing volumes averaged 63.9 million cubic feet per day in Q1, up from 59.9 MMcf/d a year earlier.Crude gathering rose to 129,451 barrels per day for the quarter ended Mar. 31, down from 122,226 b/d a year earlier.Midland Gathering System crude volumes fell to 218,203 b/d for the quarter, down from 246,090 b/d a year earlier, the company added.Delek reported Plains Connection volumes of 212,359 b/d for the quarter, up from 179,240 b/d a year earlier.Terminalling throughputs averaged 135,744 b/d, compared with 135,404 a year earlier, while West Texas marketing volumes rose to 11,771 b/d from 10,826 b/d a year earlier.Crude pipeline volumes, non-gathered, averaged 62,758 b/d in Q1, up from 61,888 b/d a year earlier, while refined products pipelines to Enterprise Systems fell to 44,658 b/d, from 56,010 b/d a year earlier.El Dorado Gathering System volumes declined to 9,220 b/d from 10,321 b/d a year earlier, while East Texas Crude Logistics System volumes rose slightly to 27,284 b/d from 26,918 b/d over the year.Delek Logistics completed drilling of its first acid gas injection well at the Libby Gas Complex during the quarter, advancing its sour gas processing and handling capabilities in the Delaware Basin.Price: $52.52, Change: $+1.66, Percent Change: +3.26%

$DKL

Asia Markets55d ago

DAX Index Declines as German Inflation Jumps

Local equities were closed lower on Wednesday, as the market weighed Germany's latest inflation figures against the anticipated US Federal Reserve interest rate decision due later in the day.Amid a busy day for economic and corporate updates, the blue-chip DAX index closed the session 0.27% in the red.Preliminary data from Destatis showed German annual inflation accelerated to 2.9% in April from the previous 2.7%, behind the market forecast of 3%. The core inflation rate, which excludes food and energy prices, declined to 2.3% from 2.5% a month ago."Turning to the ECB, German inflation data adds to the evidence of increasing stagflationary pressures ahead of tomorrow's policy meeting. As much as the rise in actual inflation and inflation expectations will fuel the rate hike debate, growing signs of adverse growth effects will make aggressive rate hikes less straightforward," ING noted.Meanwhile, the ifo Institute said that German companies are accelerating their headcount reductions in response to persistent global instability, noting the layoffs are affecting nearly every industry sector. The ifo Employment Barometer fell to 91.3 points in April 2026, down from 93.4 points a month ago, hitting the lowest level since May 2020.On the corporate side, adidas (ADS.F) soared to the top of the DAX, climbing 8.35%, after outperforming first-quarter expectations and sticking to its full-year targets. The German sportswear giant posted a 14% increase in currency-neutral revenue to 6.59 billion euros, surpassing the consensus of 9% growth, and expects a high-single-digit currency-neutral sales jump for 2026, corresponding to 2 billion euros in absolute terms."Overall, a good print with the only major question likely to be the relative weakness of footwear in the mix and how much of the beat came from World Cup products. In our view, this is a strong performance with adidas winning in a number of important categories. Trading on 15x the stock was not pricing in a FY upgrade at this stage and we see this as likely to be enough to see a positive reaction today," Deutsche Bank Research wrote.On the other hand, Mercedes-Benz Group (MBG.F) reported a 5% decline in first-quarter revenue to 31.60 billion euros, with a sharp sales slump in China eclipsing rising demand for electric vehicles and growth across US and European markets. The German automaker was down 0.56% at closing.

^DAX$ADS.F$MBG.F

Showing 32861-32880 of 45445

Asia Markets55d ago

Swiss Blue-chip Index Extends Losses; UBS Shares Up

^SSMI$SDZ.SW$UBSG.SW